Literature DB >> 21733087

Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study.

Ewa Wunsch1, Barbara Szymanik, Michał Post, Wojciech Marlicz, Marta Mydłowska, Piotr Milkiewicz.   

Abstract

BACKGROUND: Minimal hepatic encephalopathy (HE) is a serious complication of cirrhosis; however, the impact of minimal HE on health-related quality of life (HRQoL) remains controversial. The Psychometric Hepatic Encephalopathy Score (PHES) remains a 'gold standard' for the assessment of minimal HE, but its results clearly differ between studied populations. AIM: We studied the effect of minimal HE on patient HRQoL.
METHODS: Eighty-seven consecutive cirrhotic patients were included. All patients underwent clinical and psychometric evaluation at the same day. Ten subjects with overt HE confirmed with West Haven criteria were excluded from the study, thus 77 patients were finally analysed. Patients with minimal HE were identified on the grounds of altered PHES. HRQoL was assessed by the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) and the Chronic Liver Disease Questionnaire (CLDQ). Normative reference data for PHES were established from a cohort of 305 healthy Polish subjects.
RESULTS: Twenty-nine (37.7%) patients were diagnosed with minimal HE. When patients with and without minimal HE were compared, HRQoL was not significantly different in none of the SF-36 and CLDQ domains.
CONCLUSION: Minimal HE does not affect HRQoL.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21733087     DOI: 10.1111/j.1478-3231.2011.02465.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

Review 1.  Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses.

Authors:  Pranav Periyalwar; Srinivasan Dasarathy
Journal:  Clin Liver Dis       Date:  2012-01-23       Impact factor: 6.126

2.  Diagnosis of covert hepatic encephalopathy without specialized tests.

Authors:  Eiman Nabi; Leroy R Thacker; James B Wade; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Douglas M Heuman; Iliana Bouneva; Arun J Sanyal; Mohammad S Siddiqui; Velimir Luketic; Melanie B White; Pamela Monteith; Nicole A Noble; Ariel Unser; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-19       Impact factor: 11.382

Review 3.  Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy -current validation level and practical use.

Authors:  Mads Kingo Guldberg Hansen; Kristoffer Kjærgaard; Lotte Lindgreen Eriksen; Lea Ladegaard Grønkjær; Anne Catrine Daugaard Mikkelsen; Thomas Damgaard Sandahl; Hendrik Vilstrup; Karen Louise Thomsen; Mette Munk Enok Lauridsen
Journal:  Metab Brain Dis       Date:  2022-02-01       Impact factor: 3.584

4.  Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis.

Authors:  Jasmohan S Bajaj; Michael Ellwood; Timothy Ainger; Thomas Burroughs; Andrew Fagan; Edith A Gavis; Douglas M Heuman; Michael Fuchs; Binu John; James B Wade
Journal:  Clin Transl Gastroenterol       Date:  2017-07-27       Impact factor: 4.488

5.  KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2020-01-10

6.  Persistent repeated measurements by magnetic resonance spectroscopy demonstrate minimal hepatic encephalopathy: a case report.

Authors:  C Scheau; G A Popa; A E Ghergus; E M Preda; R A Capsa; I G Lupescu
Journal:  J Med Life       Date:  2013-09-25

7.  Predictors of health-related quality of life in outpatients with cirrhosis: results from a prospective cohort.

Authors:  Maja Thiele; Gro Askgaard; Hans B Timm; Ole Hamberg; Lise L Gluud
Journal:  Hepat Res Treat       Date:  2013-12-22

8.  Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.

Authors:  Jen-Kuei Peng; Nilay Hepgul; Irene J Higginson; Wei Gao
Journal:  Palliat Med       Date:  2018-10-22       Impact factor: 4.762

Review 9.  Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues.

Authors:  Sara Montagnese; Jasmohan S Bajaj
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.